Ayaan A Alam

Array ( [id] => 7632893 [patent_doc_number] => 06664441 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Compound assay' [patent_app_type] => B1 [patent_app_number] => 09/549411 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6510 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664441.pdf [firstpage_image] =>[orig_patent_app_number] => 09549411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093631 [patent_doc_number] => 06825395 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-30 [patent_title] => 'Transgenic non-human mammals expressing the human complement inhibitor (DAF/CD55)' [patent_app_type] => B1 [patent_app_number] => 09/462740 [patent_app_country] => US [patent_app_date] => 2000-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5759 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825395.pdf [firstpage_image] =>[orig_patent_app_number] => 09462740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408726 [patent_doc_number] => 06239117 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Gene therapy for regulating bladder smooth muscle tone' [patent_app_type] => 1 [patent_app_number] => 9/531968 [patent_app_country] => US [patent_app_date] => 2000-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 33 [patent_no_of_words] => 23134 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239117.pdf [firstpage_image] =>[orig_patent_app_number] => 531968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406279 [patent_doc_number] => 06271211 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Gene therapy for regulating penile smooth muscle tone' [patent_app_type] => 1 [patent_app_number] => 9/532138 [patent_app_country] => US [patent_app_date] => 2000-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 33 [patent_no_of_words] => 23343 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271211.pdf [firstpage_image] =>[orig_patent_app_number] => 532138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420185 [patent_doc_number] => 06509514 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-21 [patent_title] => 'Chimeric animal model susceptible to human hepatitis C virus infection' [patent_app_type] => B1 [patent_app_number] => 09/528120 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 11383 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/509/06509514.pdf [firstpage_image] =>[orig_patent_app_number] => 09528120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409180 [patent_doc_number] => 06271435 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Leukotriene B4 receptor transgenic mice' [patent_app_type] => 1 [patent_app_number] => 9/524302 [patent_app_country] => US [patent_app_date] => 2000-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 7904 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271435.pdf [firstpage_image] =>[orig_patent_app_number] => 524302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1265871 [patent_doc_number] => 06660906 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Tpl2 transgenic knockout mice' [patent_app_type] => B1 [patent_app_number] => 09/522775 [patent_app_country] => US [patent_app_date] => 2000-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 34 [patent_no_of_words] => 22952 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660906.pdf [firstpage_image] =>[orig_patent_app_number] => 09522775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1393247 [patent_doc_number] => 06548740 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Methods for creating transgenic animals' [patent_app_type] => B1 [patent_app_number] => 09/502264 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18944 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548740.pdf [firstpage_image] =>[orig_patent_app_number] => 09502264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636285 [patent_doc_number] => 06380374 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Human intestinal Npt2B' [patent_app_type] => B1 [patent_app_number] => 09/499964 [patent_app_country] => US [patent_app_date] => 2000-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13454 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380374.pdf [firstpage_image] =>[orig_patent_app_number] => 09499964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1181363 [patent_doc_number] => 06740794 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-25 [patent_title] => 'Methods of isolating the androgenic sex hormone from crustacean prawn and marine shrimp and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/494149 [patent_app_country] => US [patent_app_date] => 2000-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 21647 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740794.pdf [firstpage_image] =>[orig_patent_app_number] => 09494149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1167600 [patent_doc_number] => 06753139 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-22 [patent_title] => 'Gene silencing' [patent_app_type] => B1 [patent_app_number] => 09/491549 [patent_app_country] => US [patent_app_date] => 2000-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9017 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753139.pdf [firstpage_image] =>[orig_patent_app_number] => 09491549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521984 [patent_doc_number] => 06414218 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Mouse model for rheumatoid arthritis' [patent_app_type] => B1 [patent_app_number] => 09/483897 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 31 [patent_no_of_words] => 4413 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414218.pdf [firstpage_image] =>[orig_patent_app_number] => 09483897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534381 [patent_doc_number] => 06489141 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Nucleic acid sequence and methods for selectively expressing a protein in a target cell or tissue' [patent_app_type] => B1 [patent_app_number] => 09/479645 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 35 [patent_no_of_words] => 89640 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489141.pdf [firstpage_image] =>[orig_patent_app_number] => 09479645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1335592 [patent_doc_number] => 06593139 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Initiation of full mammalian oocyte activation by multiple sperm components' [patent_app_type] => B1 [patent_app_number] => 09/478848 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12058 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593139.pdf [firstpage_image] =>[orig_patent_app_number] => 09478848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625612 [patent_doc_number] => 06723557 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-20 [patent_title] => 'Caenorhabditis elegans LOV-1 gene' [patent_app_type] => B1 [patent_app_number] => 09/479467 [patent_app_country] => US [patent_app_date] => 2000-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 44259 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723557.pdf [firstpage_image] =>[orig_patent_app_number] => 09479467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1597359 [patent_doc_number] => 06492575 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Method for developing transgenic mice' [patent_app_type] => B1 [patent_app_number] => 09/242406 [patent_app_country] => US [patent_app_date] => 1999-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7623 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492575.pdf [firstpage_image] =>[orig_patent_app_number] => 09242406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7644069 [patent_doc_number] => 06428969 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Method for determining oncogenic activity of a substance' [patent_app_type] => B1 [patent_app_number] => 09/473456 [patent_app_country] => US [patent_app_date] => 1999-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9157 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428969.pdf [firstpage_image] =>[orig_patent_app_number] => 09473456 [rel_patent_id] =>[rel_patent_doc_number] =>)